Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05023070 · ClinicalTrials.gov registry record · Phase 1

Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDA

A Phase 1 study of Healthy, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
Phase 1
Development phase
24
Enrollment target
1
Study location

NCT05023070 is a Phase 1 study of Healthy that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05023070, a Phase 1 study of Healthy, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
Phase 1
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of the current study is to evaluate the bioavailability of CBD in normal healthy Individuals. This is an open cross-over design study in healthy individuals to assess the safety and pharmacokinetic (PK) effects of cannabidiol.

Conditions Studied

Healthy

Interventions

  • DRUG Cannabidiol

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-07-22
Est. Completion 2023-02-16
Phase Phase 1

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05023070

The ClinicalTrials.gov registry entry for NCT05023070 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Cannabidiol is the first listed.

NCT05023070 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05023070 about?

NCT05023070 is a clinical study titled "Investigation of the Pharmacokinetic Profile of CBD - Phase 1 ANANDA". The goal of the current study is to evaluate the bioavailability of CBD in normal healthy Individuals. This is an open cross-over design study in healthy individuals to assess the safety and pharmacokinetic (PK) effects of cannabidiol.

What is the current status of trial NCT05023070?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2021-07-22. Estimated completion is 2023-02-16.

What conditions does trial NCT05023070 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT05023070?

The interventions under investigation include: Cannabidiol (DRUG).

Who is sponsoring clinical trial NCT05023070?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05023070 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Healthy

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.